日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit

晚期癌症患者入组I期临床试验单元的障碍

Fu, Siqing; McQuinn, Lacey; Naing, Aung; Wheler, Jennifer J; Janku, Filip; Falchook, Gerald S; Piha-Paul, Sarina A; Tu, Dennis; Howard, Adrienne; Tsimberidou, Apostolia; Zinner, Ralph; Hong, David S; Kurzrock, Razelle

Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.

培利福新联合多西他赛治疗铂类和紫杉烷类耐药或难治性高级别上皮性卵巢癌患者

Fu Siqing, Hennessy Bryan T, Ng Chaan S, Ju Zhenlin, Coombes Kevin R, Wolf Judith K, Sood Anil K, Levenback Charles F, Coleman Robert L, Kavanagh John J, Gershenson David M, Markman Maurie, Dice Kristine, Howard Adrienne, Li Jane, Li Yang, Stemke-Hale Katherine, Dyer Mary, Atkinson Edward, Jackson Ed, Kundra Vikas, Kurzrock Razelle, Bast Robert C Jr, Mills Gordon B